American International Group, Inc. Adverum Biotechnologies, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.81 - $1.34 $34,936 - $57,795	-43,131 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.23 - $1.95 $3,733 - $5,918	-3,035 Reduced 6.57%	43,131 $57,000
Q4 2021 Feb 11, 2022	SELL	$1.74 - $2.4 $2,406 - $3,319	-1,383 Reduced 2.91%	46,166 $81,000
Q3 2021 Nov 12, 2021	SELL	$2.08 - $3.6 $2,348 - $4,064	-1,129 Reduced 2.32%	47,549 $103,000
Q2 2021 Aug 13, 2021	SELL	$3.36 - $10.56 $10,755 - $33,802	-3,201 Reduced 6.17%	48,678 $170,000
Q1 2021 May 07, 2021	BUY	$9.26 - $14.36 $1,259 - $1,952	136 Added 0.26%	51,879 $512,000
Q4 2020 Feb 12, 2021	SELL	$9.84 - $14.26 $2,036 - $2,951	-207 Reduced 0.4%	51,743 $561,000
Q3 2020 Nov 04, 2020	BUY	$10.3 - $21.64 $75,066 - $157,712	7,288 Added 16.32%	51,950 $535,000
Q2 2020 Aug 12, 2020	BUY	$8.53 - $25.64 $61,680 - $185,402	7,231 Added 19.32%	44,662 $933,000
Q1 2020 May 04, 2020	BUY	$7.98 - $16.32 $28,967 - $59,241	3,630 Added 10.74%	37,431 $366,000
Q4 2019 Feb 05, 2020	SELL	$5.12 - $12.22 $1,454 - $3,470	-284 Reduced 0.83%	33,801 $389,000
Q3 2019 Nov 08, 2019	BUY	$5.24 - $15.89 $1,613 - $4,894	308 Added 0.91%	34,085 $186,000
Q2 2019 Aug 13, 2019	SELL	$5.1 - $11.89 $4,794 - $11,176	-940 Reduced 2.71%	33,777 $402,000
Q1 2019 May 06, 2019	SELL	$3.03 - $6.02 $3,411 - $6,778	-1,126 Reduced 3.14%	34,717 $182,000
Q4 2018 Feb 13, 2019	SELL	$2.87 - $5.92 $789 - $1,628	-275 Reduced 0.76%	35,843 $113,000
Q3 2018 Nov 09, 2018	BUY	$4.5 - $7.6 $2,929 - $4,947	651 Added 1.84%	36,118 $219,000
Q2 2018 Aug 08, 2018	BUY	$5.3 - $6.9 $187,975 - $244,722	35,467 New	35,467 $188,000

Others Institutions Holding ADVM

# of Institutions

Shares Held

524K

Call Options Held

Put Options Held

Versant Venture Management, LLC San Francisco, CA

507K
Shares

$2.4 Million
9.32% of portfolio
Pinz Capital Management, LP New York, NY

15.7K
Shares

$74,418
0.03% of portfolio
American Portfolios Advisors Holbrook, NY

1.15K
Shares

$5,451
0.0% of portfolio

View Full List

About Adverum Biotechnologies, Inc.

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

More about ADVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account